The U.S. Attorney’s office charged the companies with violating federal anti-kickback statutes in 2007. The companies avoided prosecution by agreeing to strict compliance procedures and federal monitoring.
Zimmer, Depuy, Biomet and Smith & Nephew remain subject to the terms of separate agreements entered into with the Office of Inspector General of the Department of Health and Human Services until 2012.
Read the Star-Ledger‘s report on the end of federal oversight for orthopedic device companies.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.